Akèy › Kansè Selil Jèm ak Anbrionè
Etid klinik pou Kansè Selil Jèm ak Anbrionè ap rekrite nan Etazini
21 etid pou Kansè Selil Jèm ak Anbrionè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX6 etid
- Columbus, OH5 etid
- New York City, NY5 etid
- St. Louis, MO4 etid
- Indianapolis, IN4 etid
- Chicago, IL4 etid
- Memphis, TN3 etid
- Winston-Salem, NC3 etid
- Greenburgh, NY3 etid
- Dallas, TX3 etid
- Boston, MA3 etid
- San Francisco, CA3 etid
- Mountain View, CA3 etid
- Clifton, NJ3 etid
- Minneapolis, MN3 etid
- San Antonio, TX3 etid
- San Bernardino, CA3 etid
Pa eta
- Florid3 etid
- Georgia3 etid
- Illinois4 etid
- Indiana4 etid
- Kalifòni7 etid
- Massachusetts3 etid
- Michigan3 etid
- Minnesota3 etid
- Missouri4 etid
- New Jersey4 etid
- New York6 etid
- North Carolina3 etid
- Ohio5 etid
- Pennsylvania3 etid
- Tennessee4 etid
- Texas7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Ap rekriteFaz 3
Laj 11 a 50 · Tout sèks · Mizajou Sep 1, 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Aug 25, 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 15 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06276491Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Ap rekriteFaz 1/2
Laj 12 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT05092451C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Ap rekriteFaz 1
12 Months – 25 Years · Tout sèks · Mizajou Aug 3, 2026 · NCT04099797Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07628634A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2026 · NCT06866964Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Ap rekriteFaz 1/2
Laj 4 a 39 · Tout sèks · Mizajou Jul 20, 2026 · NCT05278208Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jul 10, 2026 · NCT06828185A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT04804007A Study of ZW251 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT07164313A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Ap rekriteFaz 1 bonè
Laj 3 a 21 · Tout sèks · Mizajou Apr 29, 2026 · NCT07017816Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Apr 15, 2026 · NCT04308330The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Apr 13, 2026 · NCT01890486Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Ap rekriteFaz 1
Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038Germ Cell Tumor and Testicular Tumor DNA Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT02099734Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT06937866Molecular Epidemiology of Pediatric Germ Cell Tumors
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 24, 2025 · NCT05564026Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.